Latest News | BIZ-STOCKS-ASTRAZENECA AstraZeneca Pharma Shares Tank over 13 Pc on COVID-19 Vaccine Study Roadblock
Get latest articles and stories on Latest News at LatestLY. Shares of AstraZeneca Pharma on Wednesday plunged over 13 per cent after its COVID-19 vaccine study was paused following a participant's unexplained illness.
New Delhi, Sep 9 (PTI) Shares of AstraZeneca Pharma on Wednesday plunged over 13 per cent after its COVID-19 vaccine study was paused following a participant's unexplained illness.
The stock tumbled 13.40 per cent to Rs 3,650 on the BSE.
Also Read | Redmi 9A Online India Sale Today at 12 Noon via Amazon.in & Mi.com, Prices & Offers.
On the NSE, it tanked 12.31 per cent to Rs 3,710.
As per reports, late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot.
Also Read | Redmi Smart Band First Sale Today in India at 1 PM IST via Amazon.in & Mi.com.
In a statement issued on Tuesday evening, the company said its "standard review process triggered a pause to vaccination to allow review of safety data".
AstraZeneca didn't reveal any information about the possible side effect except to call it "a potentially unexplained illness".
The health news site STAT first reported the pause in testing, saying the possible side effect occurred in the United Kingdom. An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the US and other countries.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)